Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Viridian Therapeutics, Inc./DE (VRDN) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Viridian Therapeutics, Inc./DE (VRDN), most recent 12 months reported: revenue $71.13M, net loss $386.97M, free cash flow -$335.04M. Latest balance sheet on file: liquid cash $816.54M, total debt $355.8M, net cash $460.74M. From SEC filings. Others in Pharmaceutical Preparations: Standard BioTools Inc. · ADC Therapeutics SA · KURA ONCOLOGY, INC. · Assembly Biosciences, Inc. · ROCKWELL MEDICAL, INC. · Fortress Biotech, Inc. · Journey Medical Corp · CYTOKINETICS, INCORPORATED

Stock screener

Watchlist